Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

specific

A clinically aggressive neoplasm derived from the precursors of plasmacytoid dendritic cells (also called professional type I interferon-producing cells or plasmacytoid monocytes), with a high frequency of cutaneous and bone marrow involvement and leukemic dissemination. (WHO 2017)

Centers

Active Trials

$2M

Cancer Funding

Top Centers for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Moffitt Cancer CenterTampa, FL NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	71.8
2	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical High-Volume Research Center	High-Volume Research Center	2	—	71.8
3	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	53.1
4	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	53.1
5	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	53.1
6	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	1	—	53.1
7	Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program	Active Research Program	1	—	53.1
8	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	53.1
9	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	1	—	53.1
10	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	53.1
11	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	1	—	53.1
12	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	1	—	53.1
13	Stephenson Cancer CenterOklahoma City, OK NCI Clinical Active Research Program	Active Research Program	1	—	53.1
14	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	1	—	53.1
15	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	1	—	53.1
16	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	—	$2M	50.6
17	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive		—	—	33.1
18	Duke Cancer InstituteDurham, NC NCI Comprehensive		—	—	33.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →